Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

UNR/CSDE1 Drives a Post-transcriptional Program to Promote Melanoma Invasion and Metastasis.

Wurth L, Papasaikas P, Olmeda D, Bley N, Calvo GT, Guerrero S, Cerezo-Wallis D, Martinez-Useros J, García-Fernández M, Hüttelmaier S, Soengas MS, Gebauer F.

Cancer Cell. 2019 Sep 16;36(3):337. doi: 10.1016/j.ccell.2019.08.013. No abstract available.

PMID:
31526761
2.

p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors.

Karras P, Riveiro-Falkenbach E, Cañón E, Tejedo C, Calvo TG, Martínez-Herranz R, Alonso-Curbelo D, Cifdaloz M, Perez-Guijarro E, Gómez-López G, Ximenez-Embun P, Muñoz J, Megias D, Olmeda D, Moscat J, Ortiz-Romero PL, Rodríguez-Peralto JL, Soengas MS.

Cancer Cell. 2019 Jan 14;35(1):46-63.e10. doi: 10.1016/j.ccell.2018.11.008. Epub 2018 Dec 20.

PMID:
30581152
3.

Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1.

Cifdaloz M, Osterloh L, Graña O, Riveiro-Falkenbach E, Ximénez-Embún P, Muñoz J, Tejedo C, Calvo TG, Karras P, Olmeda D, Miñana B, Gómez-López G, Cañon E, Eyras E, Guo H, Kappes F, Ortiz-Romero PL, Rodríguez-Peralto JL, Megías D, Valcárcel J, Soengas MS.

Nat Commun. 2017 Dec 21;8(1):2249. doi: 10.1038/s41467-017-02353-y.

4.

Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine.

Olmeda D, Cerezo-Wallis D, Riveiro-Falkenbach E, Pennacchi PC, Contreras-Alcalde M, Ibarz N, Cifdaloz M, Catena X, Calvo TG, Cañón E, Alonso-Curbelo D, Suarez J, Osterloh L, Graña O, Mulero F, Megías D, Cañamero M, Martínez-Torrecuadrada JL, Mondal C, Di Martino J, Lora D, Martinez-Corral I, Bravo-Cordero JJ, Muñoz J, Puig S, Ortiz-Romero P, Rodriguez-Peralto JL, Ortega S, Soengas MS.

Nature. 2017 Jun 28;546(7660):676-680. doi: 10.1038/nature22977.

5.

UNR/CSDE1 Drives a Post-transcriptional Program to Promote Melanoma Invasion and Metastasis.

Wurth L, Papasaikas P, Olmeda D, Bley N, Calvo GT, Guerrero S, Cerezo-Wallis D, Martinez-Useros J, García-Fernández M, Hüttelmaier S, Soengas MS, Gebauer F.

Cancer Cell. 2016 Nov 14;30(5):694-707. doi: 10.1016/j.ccell.2016.10.004. Epub 2016 Oct 27. Erratum in: Cancer Cell. 2019 Sep 16;36(3):337.

6.

The nuclear corepressor 1 and the thyroid hormone receptor β suppress breast tumor lymphangiogenesis.

Martínez-Iglesias O, Olmeda D, Alonso-Merino E, Gómez-Rey S, González-López AM, Luengo E, Soengas MS, Palacios J, Regadera J, Aranda A.

Oncotarget. 2016 Nov 29;7(48):78971-78984. doi: 10.18632/oncotarget.12978.

7.

Metastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5.

García-Fernández M, Karras P, Checinska A, Cañón E, Calvo GT, Gómez-López G, Cifdaloz M, Colmenar A, Espinosa-Hevia L, Olmeda D, Soengas MS.

Autophagy. 2016 Oct 2;12(10):1776-1790. Epub 2016 Jul 27.

8.

Erratum to: Vegfr3-CreER T2 mouse, a new genetic tool for targeting the lymphatic system.

Martinez-Corral I, Stanczuk L, Frye M, Ulvmar MH, Diéguez-Hurtado R, Olmeda D, Makinen T, Ortega S.

Angiogenesis. 2016 Jul;19(3):447. No abstract available.

PMID:
27272322
9.

Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system.

Martinez-Corral I, Stanczuk L, Frye M, Ulvmar MH, Diéguez-Hurtado R, Olmeda D, Makinen T, Ortega S.

Angiogenesis. 2016 Jul;19(3):433-45. doi: 10.1007/s10456-016-9505-x. Epub 2016 Mar 18. Erratum in: Angiogenesis. 2016 Jul;19(3):447.

PMID:
26993803
10.

Vesicular trafficking mechanisms in endothelial cells as modulators of the tumor vasculature and targets of antiangiogenic therapies.

Maes H, Olmeda D, Soengas MS, Agostinis P.

FEBS J. 2016 Jan;283(1):25-38. doi: 10.1111/febs.13545. Epub 2015 Oct 29. Review.

11.

Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMT.

Díaz-López A, Díaz-Martín J, Moreno-Bueno G, Cuevas EP, Santos V, Olmeda D, Portillo F, Palacios J, Cano A.

Int J Cancer. 2015 Feb 15;136(4):E62-73. doi: 10.1002/ijc.29177. Epub 2014 Sep 12.

12.

RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway.

Alonso-Curbelo D, Riveiro-Falkenbach E, Pérez-Guijarro E, Cifdaloz M, Karras P, Osterloh L, Megías D, Cañón E, Calvo TG, Olmeda D, Gómez-López G, Graña O, Sánchez-Arévalo Lobo VJ, Pisano DG, Wang HW, Ortiz-Romero P, Tormo D, Hoek K, Rodríguez-Peralto JL, Joyce JA, Soengas MS.

Cancer Cell. 2014 Jul 14;26(1):61-76. doi: 10.1016/j.ccr.2014.04.030. Epub 2014 Jun 26.

13.

In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis.

Martínez-Corral I, Olmeda D, Diéguez-Hurtado R, Tammela T, Alitalo K, Ortega S.

Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6223-8. doi: 10.1073/pnas.1115542109. Epub 2012 Apr 2.

14.

Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth.

Abéngozar MA, de Frutos S, Ferreiro S, Soriano J, Perez-Martinez M, Olmeda D, Marenchino M, Cañamero M, Ortega S, Megias D, Rodriguez A, Martínez-Torrecuadrada JL.

Blood. 2012 May 10;119(19):4565-76. doi: 10.1182/blood-2011-09-380006. Epub 2012 Mar 23.

PMID:
22446484
15.

A Cre-reporter transgenic mouse expressing the far-red fluorescent protein Katushka.

Diéguez-Hurtado R, Martín J, Martínez-Corral I, Martínez MD, Megías D, Olmeda D, Ortega S.

Genesis. 2011 Jan;49(1):36-45. doi: 10.1002/dvg.20685. Epub 2011 Jan 3.

PMID:
21254335
16.

Hyaluronic acid/chitosan-g-poly(ethylene glycol) nanoparticles for gene therapy: an application for pDNA and siRNA delivery.

Raviña M, Cubillo E, Olmeda D, Novoa-Carballal R, Fernandez-Megia E, Riguera R, Sánchez A, Cano A, Alonso MJ.

Pharm Res. 2010 Dec;27(12):2544-55. doi: 10.1007/s11095-010-0263-y. Epub 2010 Sep 21.

PMID:
20857179
17.

The morphological and molecular features of the epithelial-to-mesenchymal transition.

Moreno-Bueno G, Peinado H, Molina P, Olmeda D, Cubillo E, Santos V, Palacios J, Portillo F, Cano A.

Nat Protoc. 2009;4(11):1591-613. doi: 10.1038/nprot.2009.152. Epub 2009 Oct 15.

PMID:
19834475
18.

Snai1 and Snai2 collaborate on tumor growth and metastasis properties of mouse skin carcinoma cell lines.

Olmeda D, Montes A, Moreno-Bueno G, Flores JM, Portillo F, Cano A.

Oncogene. 2008 Aug 7;27(34):4690-701. doi: 10.1038/onc.2008.118. Epub 2008 Apr 14.

PMID:
18408755
19.

SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells.

Olmeda D, Moreno-Bueno G, Flores JM, Fabra A, Portillo F, Cano A.

Cancer Res. 2007 Dec 15;67(24):11721-31. Erratum in: Cancer Res. 2008 Feb 1;68(3):956.

20.

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Peinado H, Olmeda D, Cano A.

Nat Rev Cancer. 2007 Jun;7(6):415-28. Epub 2007 May 17. Review.

PMID:
17508028
21.

Id-1 is induced in MDCK epithelial cells by activated Erk/MAPK pathway in response to expression of the Snail and E47 transcription factors.

Jordà M, Vinyals A, Marazuela A, Cubillo E, Olmeda D, Valero E, Cano A, Fabra A.

Exp Cell Res. 2007 Jul 1;313(11):2389-403. Epub 2007 May 9.

PMID:
17490644
22.

Snail silencing effectively suppresses tumour growth and invasiveness.

Olmeda D, Jordá M, Peinado H, Fabra A, Cano A.

Oncogene. 2007 Mar 22;26(13):1862-74. Epub 2006 Oct 9.

PMID:
17043660
23.

A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression.

Peinado H, Del Carmen Iglesias-de la Cruz M, Olmeda D, Csiszar K, Fong KS, Vega S, Nieto MA, Cano A, Portillo F.

EMBO J. 2005 Oct 5;24(19):3446-58. Epub 2005 Aug 18.

24.

Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor.

Jordà M, Olmeda D, Vinyals A, Valero E, Cubillo E, Llorens A, Cano A, Fabra A.

J Cell Sci. 2005 Aug 1;118(Pt 15):3371-85.

25.

Choline kinase activation is a critical requirement for the proliferation of primary human mammary epithelial cells and breast tumor progression.

Ramírez de Molina A, Báñez-Coronel M, Gutiérrez R, Rodríguez-González A, Olmeda D, Megías D, Lacal JC.

Cancer Res. 2004 Sep 15;64(18):6732-9.

26.

Beta-catenin regulation during the cell cycle: implications in G2/M and apoptosis.

Olmeda D, Castel S, Vilaró S, Cano A.

Mol Biol Cell. 2003 Jul;14(7):2844-60. Epub 2003 Apr 4.

Supplemental Content

Loading ...
Support Center